Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: Hawkmoon who wrote (54107)	6/12/2000 11:43:00 PM
From: LLCF	Read Replies (2) \| Respond to of 116762

<To a certain extent I agree. But then I also have to disagree because until that money from the pension funds starts to regularly flow into these sectors, only a small percentage of the "easy money" will have been made.> Ron, that's a load of crap watch and learn....as I said before, they'll be doubles before you even know what happend. I'm up 20% on HM already, and I'm sure others [GOLD] are outperforming that... how long are you going to sit on the sidelines watching the 'goldsters' outperform? common get in now the waters fine. <And the resulting flow of huge quantities of investment money into only the upper crust of the equity markets creates these bubbles that eventually get popped as money rotates to new companies or sectors.> Well, at least your using the "B" word... you're coming along fine young fella! he he <We need to see more emphasis on holding a broader array of the overall market, especially in the small cap sector, which I feel is under-represented. We've essentially seen a major bear market in the broader market for the past several years as bonus sniffing mutual fund managers play "monkey see, monkey do" in the big cap stocks.> Forget all that junk....... GOLD! That's where the action is! Anyone want to slap this guy and wake him up?? DAK

To: Hawkmoon who wrote (54107)	6/13/2000 5:41:00 AM
From: Roebear	Respond to of 116762

Ron Reece, I've got to agree with David here, "When this happens most of the money will be made, just like the oil stocks". I was (and am, to a lesser extent) heavily involved in the oil stocks when the $5 a barrel oil article came out and I can supply the posts to prove it. While a few knew it was BS, there were a lot of nervous traders double checking the fundamentals of production and demand at that time. What is obvious now, RE: "And anyone who thought the price of oil would remain at $5/barrel was delusional, or possessed an underwhelming appreciation of the monopoly power of the OPEC cartel." Was not obvious then! While those that followed oil and oil stocks had good reason to hope, it was very exasperating to know a bottom was being formed while the whole world was telling them that oil was finished and that OPEC was nothing more than a broken relic that would never again perform economic miracles. People on the street bought up the spin, as it now obviously was and went about blithely buying SUV's and didn't CARE about the thermostat, helping doom their own future personal energy budgets. Perhaps you were involved with the energy sector at that time, your handle/name sounds familiar, and if so kudos on your insight. But to be honest, did you have the same confidence at that time that your above statement implies? I think you are mistaken not to apply the same principles to the yellow dog, now, that were evident to only a few "oily" investors back in the dark days of energy. No offense or reference to the vertically challenged, but short folks may soon find out that the yellow dog has big sharp teeth and lots of'em. Best Regards, Roebear

To: Hawkmoon who wrote (54107)	9/21/2000 7:51:03 AM
From: long-gone	Respond to of 116762

Doom & Gloom report: Financial Times global -------------------------------------------------------------------------------- Bio-terror fear spurs smallpox vaccine order By David Pilling, Pharmaceuticals Correspondent Published: September 20 2000 19:10GMT \| Last Updated: September 21 2000 09:56GMT The US government, prompted by fears of bio-terrorist attack, has awarded Peptide Therapeutics, a small UK biotechnology company, a contract to produce 40m doses of vaccine against smallpox - a disease "eradicated" more than 20 years ago. Barbara Reynolds of the Centers for Disease Control, the Atlanta-based government agency, said: "There is increasing concern about bio-terrorism." Of a possible smallpox attack, she said: "Even though there may only be a low probability of it occurring, if it did occur it would be catastrophic." US defence officials have long feared that laboratory samples of smallpox might have fallen into the hands of potential terrorists or rogue states. The last case of smallpox was eliminated in Somalia in 1977. Samples have been stored in laboratories in the US and Russia. This year, the US opposed plans to destroy remaining specimens. Attention was refocused on smallpox in the early 1990s after a Soviet defector told US authorities that Moscow had a big bio-warfare programme, including smallpox. Fears within the US administration were heightened following wide circulation of The Cobra Event, a fictional account of a bio-terrorist attack on New York. The book, published in the late-1990s, mentions smallpox as a real threat. Peptide Therapeutics of Cambridge will make a stockpile of smallpox vaccine to be used on civilians if the virus is ever released. Plans are under way to produce a separate batch for the military. Peptide plans to market the vaccine to other governments, including Israel. Smallpox is highly infectious and fatal in a third of cases. It is estimated to have killed 500m people in the first 75 years of the 20th century. The disease was eradicated using a modified form of a vaccine developed by Edward Jenner, a British scientist, in 1796. Jenner made a vaccine using scabs from the hands of milkmaids after noticing that they rarely suffered from the facial scarring associated with smallpox. The disease probably resided in cow udders. Peptide's vaccine, which should be ready in 2004, is based on the related vaccinia virus strain. The contract is worth an estimated $343m over 20 years. Lance Gordon, vice-president of OraVax, the US subsidiary of Peptide, said that, in the case of terrorist attack, the vaccine would be used to create a "firewall" of immunity, preventing the virus from spreading. news.ft.com